Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden-Reference-Cited by-同舟云学术

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden

Published:2024-02 Issue:2 Volume:24 Page:e80-e81
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Marking Ulrika,Bladh Oscar,Aguilera Katherina,Yang Yiqiu,Greilert Norin Nina,Blom Kim,Hober Sophia,Klingström Jonas,Havervall Sebastian,Åberg Mikael,Sheward Daniel J,Thålin Charlotte

Funder

Knut and Alice Wallenberg Foundation

Region Stockholm

SciLifeLab

Erling Persson Family Foundation

Publisher

Elsevier BV

Reference5 articles.

1. Antibody response to omicron BA.4-BA.5 bivalent booster;Wang;N Engl J Med,2023

2. Immunogenicity of BA.5 bivalent mRNA vaccine boosters;Collier;N Engl J Med,2023

3. Safety and immunogenicity of XBB.1·5-containing mRNA vaccines;Chalkias;medRxiv,2023

4. Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination;Stankov;Lancet Infect Dis,2023

5. Correlates of protection, viral load trajectories and symptoms in BA.1, BA.1.1 and BA.2 breakthrough infections in triple vaccinated healthcare workers;Marking;medRxiv,2022

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment;Vaccine;2024-11

2. Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster;Cell Reports Medicine;2024-08

3. COVID-19 vaccine updates for people under different conditions;Science China Life Sciences;2024-07-29

4. Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial;Vaccines;2024-07-02

5. COVID-19 vaccination: 2023 Taiwan Association of Gerontology and Geriatrics (TAGG) consensus statements;Journal of the Formosan Medical Association;2024-07